Cervicogenic Headache
Conditions
Interventions
rESWT Group:treatment with rESWT
Drug Group:treatment with drugs
IFT Group:treatment with IFT
Sponsors
The First Affiliated Hospital of Kunming Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Adults with cervicogenic headache. 2. Age: 18-80 years old. 3. Patients who volunteered to participate in the study and signed the informed consent in person. 4. Patients diagnosed as cervicogenic headache according to the international classification of headache (ichd-iii).
Exclusion criteria
Exclusion criteria: 1. Patients with previous cervical fracture or cervical surgery. Cervical disc herniation, ankylosing spondylitis, scoliosis, spondylolisthesis and spondylolysis. Systemic diseases and mental diseases. 2. Patients with drug treatment contraindications include: allergic patients, patients with gastrointestinal bleeding or bleeding history, patients with renal insufficiency, patients with severe heart failure and treatment of lactating women. 3. Patients with contraindications to radiation extracorporeal shock wave: treatment of pregnant women, treatment of coagulation disorders (including local thrombosis), treatment of oral anticoagulants, treatment of local tumors, treatment of local bacterial and / or viral infections (including lumbar tuberculosis), and treatment of patients with local corticosteroids within six weeks before the first reswt meeting (if applicable). 4. Patients who participated in any other clinical trial within 12 weeks prior to possible inclusion in the proposed study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PSEQ;Muscle elasticity assessed by sonoelastography; | — |
Countries
China
Contacts
Public ContactXiaomei Zhang
The First Affiliated Hospital of Kunming Medical University
Outcome results
None listed